Загрузка...
Effectiveness of EGFR‐TKI rechallenge immediately after PD‐1 blockade failure
BACKGROUND: There is currently insufficient information available on effective therapies that can be administered to patients with non‐small cell cancer (NSCLC) who develop resistance to epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs). However, sequential treatment via progra...
Сохранить в:
| Опубликовано в: : | Thorac Cancer |
|---|---|
| Главные авторы: | , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley & Sons Australia, Ltd
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7952801/ https://ncbi.nlm.nih.gov/pubmed/33522139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13864 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|